WHO ICTRP trial
The effects of caffeine on walking and balance in patients with multiple…
IRCT2017012332142N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2017012332142N1 |
|---|---|
| Public title | The effects of caffeine on walking and balance in patients with multiple sclerosis |
| Scientific title | Determine the effect of caffeine on the ability to walk and balance in patients with multiple sclerosis |
| Primary sponsor | zahedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | multiple sclerosis. Multiple sclerosis;Multiple sclerosis |
| Interventions | Intervention 1: Consumption of caffeine, the chemical composition: pure caffeine concentration: 100%, dose: 2.5 mg per kilogram of body weight on a daily basis (minimum dose), the frequency of use: once a day, duration of use: 3 months… |
| Registration date | Mar 27, 2017 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: